Dr Hugo Ford
Oncology and Board Advisor
Digital Platform Advisor
Employer Training Presenter
HR course advisor
We are Always Open to Partners
We will be starting Randomised Controlled Trials (RCT’s) in 2022 to further understand the impact of our Cancer Rehabilitation programme in reducing the side effects of cancer treatments. We will also be measuring cost-effectiveness on Quality of Life measures and long-term survival rates in partnership with a number of international researchers in these fields.
If you are a pharmaceutical company or healthcare provider interested in partnering with us, please get in touch with us at email@example.com.
Thank you to Costello Medical for their collaboration on our health economic studies.